🔗 Permalink

Inventor profile of:

James E. Brown

City:

Los Gatos, California

Country:

United States

Published Applications:

Last publication date:

2026-04-16

Top Assignees for applications by James E. Brown

The entities that hold a legal rights for patent applications filed by inventor Brown James E.:

Durect Corporation 6 Cupertino, CA United States
VIRGINIA COMMONWEALTH UNIVERSITY 5 Richmond, VA United States
ALZA Corporation 1 Mountain View, CA United States
The United States Government, as Represented by the Department of Veterans Affairs 1 Washington, DC United States
Medicis Pharmaceutical Corporation 1 Bridgewater, NJ United States

Recent patent applications by Brown James E.

James E. Brown from Los Gatos, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-16

US20260102410A1

Human necessities

Treatment of Alcoholic Hepatitis

#2 | 2023-11-23

US20230372361A1

Human necessities

USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING INFLAMMATORY CONDITIONS

#3 | 2023-10-05

US20230310458A1

Human necessities

USES OF OXYGENATED CHOLESTEROL SULFATES (OCS)

#4 | 2023-09-14

US20230285416A1

Human necessities

USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AT LEAST ONE OF INSULIN RESISTANCE, DIABETES, AND PREDIABETES

#5 | 2023-07-13

US20230218639A1

Human necessities

USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING NEUROLOGICAL CONDITIONS, NEURODEGENERATIVE DISEASES, AND ADDICTION

#6 | 2023-06-15

US20230181602A1

Human necessities

TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)

#7 | 2023-05-11

US20230141965A1

Human necessities

TREATMENT OF INFECTIOUS DISEASES

#8 | 2022-12-01

US20220378802A1

Human necessities

TREATMENT OF ALCOHOLIC HEPATITIS

#9 | 2021-06-10

US20210169902A1

Human necessities

USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) TO TREAT INFLAMMATORY SKIN DISEASE AND SKIN LESIONS

#10 | 2021-02-18

US20210046091A1

Human necessities

Uses of oxygenated cholesterol sulfates (OCS)

#11 | 2019-12-12

US20190374554A1

Human necessities

USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) TO TREAT INFLAMMATORY SKIN DISEASE AND SKIN LESIONS

#12 | 2019-11-21

US20190350945A1

Human necessities

Uses of oxygenated cholesterol sulfates (OCS)

#13 | 2018-04-26

US20180110739A1

Human necessities

Transdermal Delivery Systems

#14 | 2017-01-19

US20170014429A1

Human necessities

Uses of oxygenated cholesterol sulfates (OCS)

#15 | 2017-01-12

US20170007549A1

Human necessities

Transdermal Delivery Systems

#16 | 2013-11-28

US20130317456A1

Human necessities

Transdermal delivery systems

#17 | 2013-10-17

US20130273139A1

Human necessities

TRANSDERMAL DELIVERY SYSTEMS

#18 | 2009-03-05

US20090060986A1

Human necessities

Transdermal delivery systems

#19 | 2008-10-16

US20080254086A1

Human necessities

Controlled Release Compositions

#20 | 2008-07-24

US20080176785A1

Human necessities

Controlled release compositions

#21 | 2007-04-19

US20070087058A1

Human necessities

Osmotic implant with membrane and membrane retention means

#22 | 2007-01-16

US10173992

Osmotic implant with membrane and membrane retention means

#23 | 2005-03-31

US20050070883A1

Human necessities

Devices and methods for controlled delivery from a drug delivery device

InventorID:

486413 ⎘